(Q33995247)

30 July 2017

1 reference

title

Review of literature on the factors affecting drug prescribing (English)

1 reference

30 July 2017

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?resulttype=core&format=json&query=SRC%3AMED%20AND%20EXT_ID%3A1093256

21 August 2022

author name string

E. Hemminki

1

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?resulttype=core&format=json&query=SRC%3AMED%20AND%20EXT_ID%3A1093256

21 August 2022

language of work or name

English

1 reference

National Center for Biotechnology Information

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/esummary.fcgi?db=pubmed&retmode=json&id=1093256

21 August 2022

publication date

1 February 1975

1 reference

full work available at URL

30 July 2017

https://api.elsevier.com/content/article/PII:0037785675901031?httpAccept=text/xml

1 reference

https://api.crossref.org/works/10.1016/0037-7856(75)90103-1

https://api.elsevier.com/content/article/PII:0037785675901031?httpAccept=text/plain

14 September 2023

1 reference

https://api.crossref.org/works/10.1016/0037-7856(75)90103-1

Social science & medicine

14 September 2023

published in

1 reference

30 July 2017

volume

9

1 reference

30 July 2017

issue

2

1 reference

30 July 2017

page(s)

111-116

1 reference

PRIMARY MEDICAL CARE. 3. PRESCRIBING IN THREE ENGLISH TOWNS.

30 July 2017

cites work

3

1 reference

https://api.crossref.org/works/10.1016/0037-7856(75)90103-1

INFLUENCE OF DIFFERENT SOURCES OF THERAPEUTIC INFORMATION ON PRESCRIBING BY GENERAL PRACTITIONERS

14 September 2023

7

1 reference

https://api.crossref.org/works/10.1016/0037-7856(75)90103-1

Physicians' orientation toward the legitimacy of drug use and their preferred source of new drug information

14 September 2023

10

1 reference

https://api.crossref.org/works/10.1016/0037-7856(75)90103-1

Drug safety in theory and practice

14 September 2023

11

1 reference

https://api.crossref.org/works/10.1016/0037-7856(75)90103-1

Market Mortality of New Products in the Pharmaceutical Industry

14 September 2023

13

1 reference

https://api.crossref.org/works/10.1016/0037-7856(75)90103-1

Differential education concerning therapeutics and resultant physician prescribing patterns

14 September 2023

15

1 reference

https://api.crossref.org/works/10.1016/0037-7856(75)90103-1

The pharmaceutical market and prescription drugs in the Federal Republic of Germany: cross-national comparisons

14 September 2023

22

1 reference

https://api.crossref.org/works/10.1016/0037-7856(75)90103-1

The overmedicated society: forces in the marketplace for medical care

14 September 2023

27

1 reference

https://api.crossref.org/works/10.1016/0037-7856(75)90103-1

Analysis of a general practitioners communications from the pharmaceutical industry

14 September 2023

31

1 reference

https://api.crossref.org/works/10.1016/0037-7856(75)90103-1

Social barriers to rational drug therapy

14 September 2023

32

1 reference

https://api.crossref.org/works/10.1016/0037-7856(75)90103-1

Advertising: Informational but Not Educational

14 September 2023

33

1 reference

https://api.crossref.org/works/10.1016/0037-7856(75)90103-1

What influences have led to increased prescribing of psychotropic drugs?

14 September 2023

34

1 reference

https://api.crossref.org/works/10.1016/0037-7856(75)90103-1

Prescribing patterns of physicians

14 September 2023

38

1 reference

https://api.crossref.org/works/10.1016/0037-7856(75)90103-1

Student reactions to pharmaceutical promotion practices

14 September 2023

39

1 reference

https://api.crossref.org/works/10.1016/0037-7856(75)90103-1

Teaching medical students to evaluate drug advertising

14 September 2023

41

1 reference

https://api.crossref.org/works/10.1016/0037-7856(75)90103-1

The use and abuses of drugs in psychiatry

14 September 2023

42

1 reference

https://api.crossref.org/works/10.1016/0037-7856(75)90103-1

Annual discourse--swinging copy and sober science

14 September 2023

45

1 reference

https://api.crossref.org/works/10.1016/0037-7856(75)90103-1

FDA and Panalba: A Conflict of Commercial, Therapeutic Goals?

14 September 2023

47

1 reference

https://api.crossref.org/works/10.1016/0037-7856(75)90103-1

Advertising and Abuse of Drugs

14 September 2023

50

1 reference

https://api.crossref.org/works/10.1016/0037-7856(75)90103-1

Social processes in physicians' adoption of a new drug

14 September 2023

51

1 reference

https://api.crossref.org/works/10.1016/0037-7856(75)90103-1

14 September 2023

52

8

1972

1 reference

https://api.crossref.org/works/10.1016/0037-7856(75)90103-1

Drug-induced Blood Dyscrasias in Sweden

14 September 2023

56

1 reference

https://api.crossref.org/works/10.1016/0037-7856(75)90103-1

Drug Control and the British Health Service

14 September 2023

60

1 reference

https://api.crossref.org/works/10.1016/0037-7856(75)90103-1

The relationship between physician characteristics and prescribing appropriateness

14 September 2023

61

1 reference

https://api.crossref.org/works/10.1016/0037-7856(75)90103-1

The doctor's role in prescribing

14 September 2023

63

1 reference

https://api.crossref.org/works/10.1016/0037-7856(75)90103-1

Why do doctors prescribe psychotropic drugs?

14 September 2023

65

1 reference

https://api.crossref.org/works/10.1016/0037-7856(75)90103-1

Dimensions of being modern in medical practice

14 September 2023

68

1 reference

https://api.crossref.org/works/10.1016/0037-7856(75)90103-1

The Diffusion of an Innovation Among Physicians

14 September 2023

69

1 reference

https://api.crossref.org/works/10.1016/0037-7856(75)90103-1

Personal factors as a cause of differences in prescribing by general practitioners

14 September 2023

70

1 reference

https://api.crossref.org/works/10.1016/0037-7856(75)90103-1

Characteristics and Attitudes of Physicians Associated with the Prescribing of Chloramphenicol

14 September 2023

72

1 reference

https://api.crossref.org/works/10.1016/0037-7856(75)90103-1

14 September 2023

Identifiers

1 reference

30 July 2017

1 reference